William E Barlow

17PUBLICATIONS
149CO-AUTHORS
Predictive and prognostic markersMolecular targetsData qualityPsychiatry (incl. psychotherapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 11, 2025
Novel Postneoadjuvant Prognostic Breast Cancer Staging System.

David J Winchester, Lavisha Singh, Stephen B Edge

|Mar 18, 2025
Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis.

Wolfgang Janni, Thomas W P Friedl, Tracy C Yab

|Mar 07, 2025
Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study.

Samer El Kababji, Nicholas Mitsakakis, Elizabeth Jonker

|Dec 10, 2024
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial.

Yara Abdou, William E Barlow, Julie R Gralow

|Dec 02, 2024
Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor-Positive, Node-Positive Breast Cancer.

Lajos Pusztai, Jess R Hoag, Kathy S Albain

|Jun 04, 2024
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer.

Mariana Chavez-MacGregor, Jieling Miao, Lajos Pusztai

Pageof 3

Frequent Collaborators

9 joint publications

Lajos Pusztai

9 joint publications

Gabriel N Hortobagyi

7 joint publications

Priyanka Sharma

7 joint publications

Daniel F Hayes